Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Farb

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Circulation|May 23, 2019
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
European Heart Journal|May 23, 2019
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
Circulation|June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumDavide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology|March 3, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Circulation|February 1, 2021
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus RecommendationsLuiz F Ybarra, Stéphane Rinfret, Emmanouil S Brilakis, et al.
Circulation|February 28, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
Circulation|October 2, 2023
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, Mohit Pahuja, Sean van Diepen, et al.
Journal of the American College of Cardiology|September 18, 2020
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert PanelDavide Capodanno, Marie-Claude Morice, Dominick J Angiolillo, et al.
American Heart Journal|October 4, 2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shockMarc D Samsky, Mitchell W Krucoff, David A Morrow, et al.
Circulation|May 23, 2019
Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
European Heart Journal|May 23, 2019
Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskPhilip Urban, Roxana Mehran, Roisin Colleran, et al.
Circulation|June 19, 2023
Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumDavide Capodanno, Roxana Mehran, Mitchell W Krucoff, et al.
Journal of the American College of Cardiology|March 3, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Circulation|February 1, 2021
Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus RecommendationsLuiz F Ybarra, Stéphane Rinfret, Emmanouil S Brilakis, et al.
Circulation|February 28, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.
Pageof 10